WASHINGTON (

TheStreet

) -- President Obama has vowed to

drag

U.S. health care into the 21st century, allocating billions of stimulus dollars to streamline the nation's byzantine health systems. With big financial incentives being dangled in front of doctors and other providers, more than

$20 billion

will be spent on electronic medical records, the cornerstone of a massive health IT overhaul. Here are some of the stocks most likely to reap the benefits of Obama's ambitious health care agenda.

McKesson

Like many big-name health care IT firms,

McKesson

(MCK) - Get Report

sells a slew of technologies, from electronic medical records to imaging, finance and Electronic Resource Planning (ERP) systems.

"It will be interesting to look into the $20 billion and see how much of it is for electronic medical records and how much is

spent on the devices

they connect to," Martin Tobias, a VC at

Ignition Partners

and CEO of

Kashless.org

, told

TheStreet

. "A lot of these records systems need to communicate with other devices in the hospital for importing and exporting X-rays, for example, and test data out of the lab."

Obama's CTO Predicts Health IT Payday

Image placeholder title

Unsurprisingly, McKesson CEO John Hammergren can't wait for the stimulus dollars to find their way to surgeons and hospitals.

"While the economy continues to affect provider purchasing, the stimulus is creating new energy in our customer base, with particularly strong interest in our clinical offering," he said, during McKesson's recent first-quarter conference call. "More than fifty percent of our health systems customers have completed their stimulus readiness assessment or are in the process of doing so and we are engaging them in the implementation planning."

McKesson's first-quarter revenue was flat compared with that in the same period last year, impacted by the loss of some U.S. pharmaceutical distribution customers. Strong cost controls, however, pushed the company's profit up.

Although McKesson is one of the biggest players in this space, it will be vying for business with a slew of competitors, predicts James Brehm, senior consultant at analyst firm Frost & Sullivan.

"I'm sure that companies like McKesson,

3M

(MMM) - Get Report

, and

GE

(GE) - Get Report

Healthcare will be among the traditional Health care/IT companies to benefit," he wrote, in an email to

TheStreet

. "Electronic Medical Records and improving patient management will be key for organizations that can capitalize from the President's new health care plan."

The analyst also expects some of Washington's dollars to flow through to partners to other tech stocks such as

Motion Computing

,

Panasonic

and

Intel

(INTC) - Get Report

.

IBM

Frost & Sullivan's Brehm thinks that

IBM

(IBM) - Get Report

is well positioned for the health care stimulus.

"If you want a good case study, look closely at IBM," he wrote in an email to

TheStreet

. "IBM Global Financing, the lending and leasing unit of IBM, has already stepped up, making up to $2 billion available to finance IT initiatives in key economic stimulus areas."

This could be a shrewd move.

"This puts them to the head of the class because, although it is designed to help health care organizations move ahead with IT projects that will improve their infrastructure, it helps them secure new business as we move through the economic recovery," Brehm said.

IBM CEO Sam Palmisano has been a vocal supporter of Obama's stimulus package, and Big Blue has a significant health care business. In addition to finance offerings from its

Cognos

acquisition, the firm provides security, compliance and server optimization technologies.

Big Blue also has an eye on the future, when individuals could upload their medical information into

secure private clouds

. IBM, for example, has already teamed up with

Google

(GOOG) - Get Report

and

Continua Health Alliance

to move data from personal medical devices into the search giant's Google Health offering.

GE

Unlike IBM, GE's healthcare division also provides specialist medical devices for radiography, imaging and electrocardiogram testing. Already well known in the medical sector, GE can tout a total "solution" encompassing medical records systems and the actual devices that collect the data.

GE has already suited up for the brave new world of digital IT, buying electronic records specialist

MedicaLogic

back in 2002 and more recently signing a

pact

with Intel to build home health care devices.

This could be a smart deal. With health care firms attempting to reduce expensive hospital stays, analyst firm DataMonitor estimates that the home health monitoring market will grow from $3 billion this year to $7.7 billion by 2012.

In GE's recent second-quarter, however, health care revenue felt the impact of soft demand and pricing pressure, although the firm saw good growth from outsourcing services.

It is also worth noting that the U.S. is not the only country with an ambitious stimulus agenda, and major health care projects are under way in places like India and China. Globally, stimulus packages could be worth around $190 billion, according to GE CEO Jeff Imelt.

GE has nonetheless been laying the foundations to support Obama's health care plan, recently launching a program called 'Stimulus Simplicity', which provides interest-free funding for organizations deploying electronic medical records.

Cerner

Cerner

(CERN) - Get Report

, regarded as one of the leaders in health care IT systems, touts a slew of products for hospitals, physicians, home care and life sciences. The company calculates that the The American Recovery and Reinvestment Act will pump a massive $53.7 billion into the U.S. health care market, and it could easily grab a slice of this money.

The firm put out an impressive set of

second-quarter results

at the end of July, with earnings rising 24% to $44 million, or 52 cents a share. Cerner's revenue increased marginally to $404 million, although its operating margin stretched from 15% to 16%.

These numbers highlight Cerner's financial health at a crucial time for the company.

Intriguingly, a larger portion of Cerner's second-quarter revenue came from maintenance and services than system sales compared with the prior year's quarter, a sign that hospitals are not buying new computer systems. This, however, may be the calm before the storm, although the firm did reduce its third-quarter revenue forecast, suggesting that it could be some time before Washington's dollars start to flow.

Cerner and its rival

Computer Programs and Systems

(CPSI) - Get Report

(CPSI) are nonetheless well positioned, according to Raj Prabhu, managing partner of Mercom Capital Group, which specializes in health care research.

"Like McKesson, these guys are on the hospital side," he told

TheStreet.com

, adding that customers will soon know what systems they can buy. The U.S. government is currently laying out its criteria for what constitutes "meaningful use" of electronic records, according to Prabhu, who says that this should be in place in October or November.

EMDEON

Although hardly a household name, the e-billing company has been making waves recently.

Emdeon

(EM)

made an impressive start to its first day of trading as a

public company

earlier this month, with shares quickly surging past their $15.50 offering price.

Emdeon handled half of all the electronic health care transactions in the U.S. last year, and is seen as well positioned to exploit Obama's ambitious

health care agenda

.

"It's a very user-friendly, streamlined system that's easily installed and their numbers are quite compelling," Scott Sweet, principal researcher at analyst firm IPO Boutique, recently told

TheStreet

. Some 92 % to 95% of the company's revenue is recurring, he added.

--Written by James Rogers in New York

Emdeon clinched sales of $444.4 million during the first six months of 2009, up from $422.9 million in the same period last year. If this continues, then the next few years could spell big money for the firm.

Follow TheStreet.com on

Twitter

and become a fan on

Facebook.